Overview
Description
Echo IQ Limited provides artificial intelligence (AI) diagnostics tool that enhance the diagnosis of structural heart disease in Australia and the United Kingdom. It operates through Houston We Have Software and Echo IQ segments. The company offers EchoSolv, an AI software for identification of aortic stenosis heart condition to physicians and healthcare facilities. It also provides software products and services for the defence and other sectors. The company was formerly known as Houston We Have Limited and changed its name to EchoIQ Limited in December 2021. Echo IQ Limited is based in Sydney, Australia.
About
CEO
Mr. Andrew Grover
Employees
0
Address
477 Pitt Street
Suite 2.114
Sydney, 2000, NSW
Australia
Suite 2.114
Sydney, 2000, NSW
Australia
Phone
61 2 9159 3719
Website
Instrument type
Common stock
Sector
Industry
Country
Australia
MIC code
CXAC